Kamil Ali-Jackson sold $73k of RIGL
director at RIGEL PHARMACEUTICALS INC. 2,500 shares at an average of $29.17, traded May 26, 2026, filed May 28, 2026.
Score components
- +15RoleDirector
- +8Trade size$73k at market
- +5Share of holdings soldSold 17% of holdings
- 0ClusterNo other insider selling within 14 days
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0000905148-26-002724, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| May 26, 2026 | SOpen-market sale Common Stock10b5-1 | -2,500 | $29.17 | $73k | 12,625 | May 28, 2026 |
Related signals
Other insiders at RIGEL PHARMACEUTICALS INC and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 9Weak | RIGEL PHARMACEUTICALS INC | Kamil Ali-Jackson director | $88k 2,500 shares | -20% | |
| 16Weak | RIGLsell RIGEL PHARMACEUTICALS INC | Walter H Moos director | $145k 4,000 shares | -24% | |
| 22Weak | RIGLsell RIGEL PHARMACEUTICALS INC | Raymond J. Furey EVP, GC, CCO & Corp Sec | $60k 2,787 shares | -7% | |
| 47Moderate | RIGEL PHARMACEUTICALS INC | Raul R Rodriguez CEO, President | $60k 52,894 shares | -3% | |
| 37Weak | RIGEL PHARMACEUTICALS INC | Dean L Schorno EVP & Chief Financial Officer | $14k 12,628 shares | -3% | |
| 30Weak | RIGEL PHARMACEUTICALS INC | David A Santos EVP, Chief Commercial Officer | $16k 14,519 shares | -4% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.